SIECZKAREK MARK M 4
4 · Wize Pharma, Inc. · Filed Aug 13, 2020
Insider Transaction Report
Form 4
SIECZKAREK MARK M
DirectorChairman
Transactions
- Award
Restricted Stock Units (RSU)
2020-08-11+150,000→ 150,000 total→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock.
- [F2]Vest quarterly over a two year period commencing on the date of the grant.